News

BioreclamationIVT has acquired TransCell Science, a privately held contract research organization (CRO) specializing in the use of primary cells for phenotypic screening assays.  With…
Read More...

Pharnext SA, a French biopharmaceutical company developing an advanced portfolio of products in the field of neurodegenerative diseases, today announced a research and development…
Read More...

Amring Pharmaceuticals Inc., a generic pharmaceutical company, announced today that it acquired six ANDAs from Luitpold Pharmaceuticals, Inc. and AlphaForce, L.L.P., a joint venture…
Read More...

Apricus Biosciences, Inc., a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it completed the sale to Ferring International…
Read More...

Abeona Therapeutics Inc., a leading clinical-stage biopharmaceutical company focused on developing gene therapies for life-threatening rare diseases, announced today that the European…
Read More...

Kitov Pharmaceuticals Holdings Ltd., an innovative biopharmaceutical company, announced today that the Company has signed a definitive License Agreement for its lead product candidate,…
Read More...

Glenmark Pharmaceuticals, a global pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) cleared the Company's Investigational New Drug (IND) application to…
Read More...

Kasten, Inc. announced that it has completed a merger with Thru Pharma LLC dba DAKOTA Life Sciences. Upon review of Dakota during the phases of the JV setup, the Board of Directors and…
Read More...

BeiGene, Ltd. and Guangzhou Development District (GDD) announced that BeiGene (Hong Kong) Co., Ltd. (BeiGene HK), a wholly owned subsidiary of BeiGene, Ltd. and GDD and its affiliate…
Read More...

NuvOx Pharma announces that the first patients have been dosed in a Phase Ib/II clinical trial for NVX-208, an oxygen therapeutic being developed for acute ischemic stroke. The trial is…
Read More...

Vernalis plc and Servier are pleased to announce that they reinforce their partnership by entering into a new two-year oncology drug discovery collaboration on an undisclosed target.…
Read More...

Concert Pharmaceuticals, Inc. announced that the results from the Company’s Phase 1 single and multiple ascending dose trial evaluating CTP-543 in healthy volunteers were presented in a…
Read More...

Drugmakers Sanofi and Regeneron said on Saturday results from a one-year test of their Dupixent product aimed at adults with eczema or moderate-to-severe atopic dermatitis (AD) had been…
Read More...

Cardiome Pharma Corp. announced that it received authorization from the French Transparency Pricing Commission to begin selling XYDALBA in France and that it has subsequently launched…
Read More...

Sartorius, a leading partner to the biopharmaceutical industry and laboratories, today signed an agreement to acquire U.S. based Essen BioScience Inc., a pioneer and leader in the field…
Read More...

Synthon Biopharmaceuticals BV, an international biopharmaceutical company that is focused on developing new molecular entities for treating cancer and autoimmune diseases, today…
Read More...

Otsuka Pharmaceutical Co., Ltd. (OPC) today announces an agreement with Neurovance, Inc. (Neurovance) under which OPC has agreed to acquire Neurovance, a privately held, venture-funded,…
Read More...

Integral Molecular and Integrated BioTherapeutics have teamed up in the fight against the global health crises posed by Ebola and Zika viruses, signing a collaborative vaccine discovery…
Read More...

Glenmark Pharmaceuticals Inc., USA, and Evestra, Inc. have completed a strategic development, license and commercialization agreement to develop and market a generic version of Merck's…
Read More...

Eli Lilly and Company announced the successful completion of its acquisition of CoLucid Pharmaceuticals, Inc. The tender offer for all outstanding shares of common stock of CoLucid, at…
Read More...